| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| 3' Untranslated Regions | 12 | 2019 | 166 | 2.030 |
Why?
|
| RNA, Messenger | 17 | 2020 | 2826 | 1.600 |
Why?
|
| CELF1 Protein | 2 | 2024 | 48 | 1.500 |
Why?
|
| MicroRNAs | 15 | 2019 | 835 | 1.400 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2024 | 217 | 1.370 |
Why?
|
| Gene Expression Profiling | 7 | 2016 | 1674 | 1.150 |
Why?
|
| Polyadenylation | 6 | 2016 | 54 | 1.020 |
Why?
|
| Protein Biosynthesis | 6 | 2022 | 669 | 1.000 |
Why?
|
| Gene Expression Regulation | 9 | 2016 | 2536 | 0.920 |
Why?
|
| Cytoplasmic Granules | 1 | 2018 | 46 | 0.610 |
Why?
|
| Calcineurin | 12 | 2007 | 100 | 0.610 |
Why?
|
| Stress, Physiological | 1 | 2018 | 265 | 0.540 |
Why?
|
| Immunity, Innate | 1 | 2019 | 375 | 0.530 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 2485 | 0.520 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 76 | 0.510 |
Why?
|
| Mice | 30 | 2024 | 17494 | 0.480 |
Why?
|
| Statistics as Topic | 1 | 2015 | 244 | 0.470 |
Why?
|
| Oxidative Stress | 2 | 2018 | 787 | 0.460 |
Why?
|
| Animals | 37 | 2024 | 33670 | 0.450 |
Why?
|
| Apoptosis | 3 | 2020 | 1788 | 0.440 |
Why?
|
| Flow Cytometry | 1 | 2016 | 814 | 0.440 |
Why?
|
| Cell Line, Tumor | 9 | 2024 | 3288 | 0.430 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 179 | 0.430 |
Why?
|
| Alternative Splicing | 1 | 2015 | 346 | 0.420 |
Why?
|
| Genetic Vectors | 2 | 2014 | 968 | 0.410 |
Why?
|
| Ribosomes | 3 | 2022 | 138 | 0.370 |
Why?
|
| Transfection | 5 | 2019 | 1076 | 0.340 |
Why?
|
| T-Lymphocytes | 4 | 2016 | 1673 | 0.340 |
Why?
|
| Molecular Biology | 1 | 2008 | 78 | 0.300 |
Why?
|
| DNA-Binding Proteins | 9 | 2020 | 2036 | 0.300 |
Why?
|
| RNA, Untranslated | 1 | 2008 | 114 | 0.300 |
Why?
|
| Cell Line | 5 | 2020 | 2787 | 0.300 |
Why?
|
| Awards and Prizes | 1 | 2008 | 62 | 0.290 |
Why?
|
| Lymphopoiesis | 1 | 2007 | 10 | 0.290 |
Why?
|
| NFATC Transcription Factors | 9 | 2007 | 41 | 0.280 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 567 | 0.270 |
Why?
|
| Epithelial Cells | 2 | 2024 | 898 | 0.270 |
Why?
|
| RNA Interference | 4 | 2016 | 495 | 0.260 |
Why?
|
| Genes, Reporter | 4 | 2016 | 387 | 0.260 |
Why?
|
| HeLa Cells | 5 | 2019 | 808 | 0.250 |
Why?
|
| Gene Expression | 1 | 2010 | 1579 | 0.250 |
Why?
|
| Herpesviridae | 1 | 2005 | 31 | 0.240 |
Why?
|
| Humans | 35 | 2024 | 121743 | 0.240 |
Why?
|
| Genome, Viral | 1 | 2005 | 172 | 0.230 |
Why?
|
| Cell Differentiation | 8 | 2016 | 1923 | 0.230 |
Why?
|
| Protein Stability | 1 | 2024 | 166 | 0.230 |
Why?
|
| Sequence Analysis, RNA | 2 | 2014 | 369 | 0.230 |
Why?
|
| Protein Kinase C | 1 | 2024 | 151 | 0.230 |
Why?
|
| Ubiquitination | 1 | 2024 | 172 | 0.220 |
Why?
|
| Sequence Alignment | 1 | 2005 | 615 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2015 | 470 | 0.220 |
Why?
|
| Cell Movement | 2 | 2016 | 846 | 0.210 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 3 | 2018 | 162 | 0.210 |
Why?
|
| Gene Dosage | 3 | 2020 | 441 | 0.210 |
Why?
|
| Phosphorylation | 2 | 2024 | 1612 | 0.210 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 1068 | 0.200 |
Why?
|
| Mice, Knockout | 8 | 2022 | 3762 | 0.200 |
Why?
|
| Host Cell Factor C1 | 1 | 2022 | 9 | 0.200 |
Why?
|
| Homocystinuria | 1 | 2022 | 21 | 0.200 |
Why?
|
| Cell Proliferation | 6 | 2016 | 2309 | 0.200 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2022 | 39 | 0.200 |
Why?
|
| Nuclear Proteins | 7 | 2015 | 1281 | 0.190 |
Why?
|
| Oxidoreductases | 1 | 2022 | 92 | 0.190 |
Why?
|
| Lymphocyte Activation | 3 | 2016 | 689 | 0.190 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 101 | 0.180 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2020 | 19 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 4333 | 0.180 |
Why?
|
| RNA | 2 | 2018 | 578 | 0.170 |
Why?
|
| Cell Survival | 3 | 2016 | 817 | 0.170 |
Why?
|
| Transcription Factors | 8 | 2006 | 2586 | 0.170 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2020 | 70 | 0.170 |
Why?
|
| Proteostasis | 1 | 2020 | 35 | 0.170 |
Why?
|
| Autophagy | 3 | 2018 | 391 | 0.170 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1999 | 24 | 0.170 |
Why?
|
| Calcium | 5 | 2016 | 1095 | 0.160 |
Why?
|
| Sirtuins | 1 | 2019 | 22 | 0.160 |
Why?
|
| RNA Isoforms | 2 | 2016 | 6 | 0.160 |
Why?
|
| Telomere Shortening | 1 | 2019 | 34 | 0.160 |
Why?
|
| Signal Transduction | 12 | 2018 | 4504 | 0.160 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 127 | 0.160 |
Why?
|
| Jurkat Cells | 2 | 2016 | 76 | 0.160 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 10 | 0.160 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2018 | 53 | 0.160 |
Why?
|
| src-Family Kinases | 1 | 2018 | 83 | 0.150 |
Why?
|
| 5' Untranslated Regions | 1 | 2018 | 59 | 0.150 |
Why?
|
| Repressor Proteins | 2 | 2022 | 810 | 0.150 |
Why?
|
| Cloning, Molecular | 3 | 2010 | 887 | 0.150 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 66 | 0.150 |
Why?
|
| RNA, Plant | 1 | 2017 | 9 | 0.150 |
Why?
|
| Cells, Cultured | 11 | 2019 | 3069 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 210 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 204 | 0.140 |
Why?
|
| Trehalose | 1 | 2017 | 20 | 0.140 |
Why?
|
| Homozygote | 1 | 2019 | 533 | 0.140 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 416 | 0.140 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 1615 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 200 | 0.140 |
Why?
|
| Myoblasts, Skeletal | 1 | 2016 | 12 | 0.140 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2016 | 23 | 0.140 |
Why?
|
| Heterozygote | 1 | 2019 | 679 | 0.140 |
Why?
|
| Kinetics | 1 | 2018 | 1317 | 0.140 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2016 | 10 | 0.130 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 101 | 0.130 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2016 | 25 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 973 | 0.130 |
Why?
|
| CD5 Antigens | 1 | 2016 | 38 | 0.130 |
Why?
|
| RNA Stability | 2 | 2014 | 85 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 100 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 215 | 0.130 |
Why?
|
| Glycolysis | 1 | 2016 | 143 | 0.130 |
Why?
|
| NADPH Oxidases | 1 | 2016 | 108 | 0.130 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2015 | 15 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 1891 | 0.130 |
Why?
|
| Alleles | 2 | 2019 | 1594 | 0.130 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 148 | 0.130 |
Why?
|
| Female | 9 | 2024 | 64492 | 0.130 |
Why?
|
| Genes, myc | 1 | 2015 | 99 | 0.130 |
Why?
|
| Myocardium | 2 | 2014 | 982 | 0.120 |
Why?
|
| Spliceosomes | 1 | 2015 | 48 | 0.120 |
Why?
|
| HIV-1 | 1 | 1999 | 471 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 172 | 0.120 |
Why?
|
| Transcription, Genetic | 4 | 2015 | 1698 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 207 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2007 | 398 | 0.120 |
Why?
|
| Hypoxia | 1 | 2016 | 246 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 418 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 351 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 492 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 251 | 0.110 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 196 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 570 | 0.110 |
Why?
|
| Lymphocytes | 3 | 2015 | 416 | 0.110 |
Why?
|
| Calcium Signaling | 3 | 2014 | 241 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 429 | 0.110 |
Why?
|
| ROC Curve | 1 | 2015 | 550 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 512 | 0.110 |
Why?
|
| Hyaluronan Receptors | 1 | 2012 | 68 | 0.100 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2015 | 295 | 0.100 |
Why?
|
| Databases, Genetic | 1 | 2015 | 469 | 0.100 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2014 | 232 | 0.100 |
Why?
|
| Mutation | 5 | 2022 | 5749 | 0.100 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 822 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2015 | 605 | 0.100 |
Why?
|
| Neoplasms | 2 | 2018 | 2748 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 155 | 0.100 |
Why?
|
| Phenotype | 3 | 2019 | 4207 | 0.100 |
Why?
|
| Embryo, Mammalian | 3 | 2022 | 453 | 0.100 |
Why?
|
| Mice, Transgenic | 7 | 2017 | 2438 | 0.090 |
Why?
|
| Uridine Monophosphate | 1 | 2009 | 8 | 0.090 |
Why?
|
| Models, Biological | 5 | 2020 | 1434 | 0.080 |
Why?
|
| Immune System | 1 | 2010 | 86 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 4278 | 0.080 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2010 | 125 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2016 | 659 | 0.080 |
Why?
|
| Neurons | 3 | 2017 | 1916 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 339 | 0.080 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2006 | 101 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2017 | 351 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2022 | 996 | 0.080 |
Why?
|
| Massachusetts | 1 | 2008 | 124 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2015 | 1475 | 0.080 |
Why?
|
| Plants | 1 | 2008 | 46 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2792 | 0.080 |
Why?
|
| Mental Disorders | 1 | 2015 | 822 | 0.080 |
Why?
|
| Thymus Gland | 1 | 2007 | 101 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2014 | 622 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2009 | 396 | 0.070 |
Why?
|
| Down-Regulation | 3 | 2019 | 700 | 0.070 |
Why?
|
| Genomics | 1 | 2015 | 1473 | 0.070 |
Why?
|
| HIV Infections | 1 | 1999 | 1863 | 0.070 |
Why?
|
| Mesoderm | 2 | 2004 | 115 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2008 | 381 | 0.070 |
Why?
|
| Base Sequence | 3 | 2016 | 3114 | 0.070 |
Why?
|
| Ribonuclease III | 1 | 2007 | 87 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 660 | 0.070 |
Why?
|
| Antigens, T-Independent | 1 | 2006 | 1 | 0.070 |
Why?
|
| Synapses | 1 | 2010 | 440 | 0.070 |
Why?
|
| Chromosomes, Mammalian | 1 | 2006 | 42 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2008 | 999 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2016 | 5906 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 317 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2019 | 740 | 0.060 |
Why?
|
| Protein Subunits | 2 | 2022 | 164 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 1003 | 0.060 |
Why?
|
| Keratinocytes | 1 | 2005 | 60 | 0.060 |
Why?
|
| Insulin-Secreting Cells | 1 | 2006 | 143 | 0.060 |
Why?
|
| Myoblasts, Cardiac | 1 | 2004 | 7 | 0.060 |
Why?
|
| Endocardium | 1 | 2004 | 46 | 0.060 |
Why?
|
| Heart Valves | 1 | 2004 | 51 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2020 | 620 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 160 | 0.060 |
Why?
|
| Growth Cones | 1 | 2003 | 17 | 0.060 |
Why?
|
| Urinary Tract | 1 | 2004 | 60 | 0.060 |
Why?
|
| Protein Transport | 2 | 2020 | 369 | 0.060 |
Why?
|
| Down Syndrome | 1 | 2006 | 194 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 549 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2006 | 517 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2006 | 415 | 0.050 |
Why?
|
| Ureter | 1 | 2004 | 93 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 471 | 0.050 |
Why?
|
| Nervous System | 1 | 2003 | 129 | 0.050 |
Why?
|
| Male | 5 | 2022 | 59138 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 261 | 0.050 |
Why?
|
| Phylogeny | 2 | 2007 | 682 | 0.050 |
Why?
|
| Cytoplasm | 2 | 2020 | 290 | 0.050 |
Why?
|
| Organelle Biogenesis | 1 | 2022 | 16 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 410 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 3870 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 55 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2022 | 73 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 669 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1591 | 0.050 |
Why?
|
| RNA Splicing | 2 | 2015 | 224 | 0.050 |
Why?
|
| Cell Nucleus | 3 | 2017 | 679 | 0.050 |
Why?
|
| Monitoring, Immunologic | 1 | 2020 | 17 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 8 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 37 | 0.040 |
Why?
|
| Hippocampus | 2 | 2010 | 805 | 0.040 |
Why?
|
| Cell Count | 1 | 2020 | 249 | 0.040 |
Why?
|
| Calcium Channels, L-Type | 1 | 1999 | 53 | 0.040 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2019 | 6 | 0.040 |
Why?
|
| Mitosis | 1 | 2020 | 239 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 122 | 0.040 |
Why?
|
| Kenya | 1 | 1999 | 51 | 0.040 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 33 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 118 | 0.040 |
Why?
|
| Genes, Viral | 1 | 1999 | 186 | 0.040 |
Why?
|
| Telomere Homeostasis | 1 | 2019 | 44 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 48 | 0.040 |
Why?
|
| Lung | 1 | 2006 | 1471 | 0.040 |
Why?
|
| Proto-Oncogenes | 1 | 2018 | 37 | 0.040 |
Why?
|
| Triterpenes | 1 | 2018 | 21 | 0.040 |
Why?
|
| Telomerase | 1 | 2019 | 167 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 325 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2018 | 63 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 923 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2020 | 526 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 327 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 222 | 0.040 |
Why?
|
| DNA, Viral | 1 | 1999 | 493 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2015 | 799 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 447 | 0.040 |
Why?
|
| Food Handling | 1 | 2017 | 19 | 0.040 |
Why?
|
| Brassica | 1 | 2017 | 13 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 2677 | 0.040 |
Why?
|
| Biological Availability | 1 | 2017 | 128 | 0.040 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 38 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 103 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2016 | 43 | 0.030 |
Why?
|
| DNA Damage | 1 | 2020 | 516 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 48 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 93 | 0.030 |
Why?
|
| Rotenone | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2016 | 97 | 0.030 |
Why?
|
| Poly A | 1 | 2016 | 60 | 0.030 |
Why?
|
| NADPH Oxidase 2 | 1 | 2016 | 40 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 99 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 169 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2018 | 617 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 11 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 10 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 376 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 49 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 63 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 67 | 0.030 |
Why?
|
| Cleavage Stimulation Factor | 1 | 2014 | 5 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 194 | 0.030 |
Why?
|
| Myotonic Dystrophy | 1 | 2016 | 146 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 302 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 463 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 391 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 187 | 0.030 |
Why?
|
| Astrocytes | 1 | 2017 | 242 | 0.030 |
Why?
|
| Calcineurin Inhibitors | 2 | 2005 | 28 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 460 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 697 | 0.030 |
Why?
|
| Transgenes | 2 | 2006 | 330 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2015 | 358 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 401 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2007 | 1102 | 0.030 |
Why?
|
| Cell Division | 2 | 2005 | 796 | 0.030 |
Why?
|
| Disease Progression | 1 | 1999 | 1970 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 651 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 1295 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 1758 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 873 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2017 | 874 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 629 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 870 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 207 | 0.020 |
Why?
|
| Liver | 1 | 2019 | 1850 | 0.020 |
Why?
|
| Action Potentials | 1 | 2014 | 499 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2016 | 511 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 347 | 0.020 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2010 | 35 | 0.020 |
Why?
|
| Biomarkers | 1 | 1999 | 2922 | 0.020 |
Why?
|
| UDPglucose-Hexose-1-Phosphate Uridylyltransferase | 1 | 2009 | 3 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 63 | 0.020 |
Why?
|
| Dendritic Spines | 1 | 2010 | 54 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 197 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2010 | 397 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 392 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 145 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 236 | 0.020 |
Why?
|
| Calcium Channels | 2 | 1999 | 160 | 0.020 |
Why?
|
| raf Kinases | 1 | 2007 | 7 | 0.020 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2007 | 58 | 0.020 |
Why?
|
| Luciferases, Firefly | 1 | 2007 | 14 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 1004 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 83 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3221 | 0.020 |
Why?
|
| RNA Polymerase III | 1 | 2007 | 38 | 0.020 |
Why?
|
| Antigens | 1 | 2007 | 161 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2007 | 260 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 144 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2007 | 74 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2006 | 5 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 150 | 0.020 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 2006 | 14 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2006 | 28 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2006 | 49 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 172 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 667 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2007 | 180 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2006 | 67 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 1004 | 0.020 |
Why?
|
| Ligands | 1 | 2007 | 537 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 517 | 0.020 |
Why?
|
| Salivary Glands | 1 | 2006 | 33 | 0.020 |
Why?
|
| Germinal Center | 1 | 2006 | 37 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2006 | 91 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2006 | 40 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2006 | 190 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 86 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2006 | 221 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 2944 | 0.020 |
Why?
|
| Alopecia | 1 | 2005 | 36 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 213 | 0.020 |
Why?
|
| Receptor, Notch1 | 1 | 2005 | 66 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 5995 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 324 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2004 | 8 | 0.010 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2004 | 7 | 0.010 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2004 | 39 | 0.010 |
Why?
|
| PAX3 Transcription Factor | 1 | 2004 | 27 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 804 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 558 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 2004 | 75 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 160 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2006 | 317 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2004 | 141 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2004 | 99 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 136 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 234 | 0.010 |
Why?
|
| Growth Hormone | 1 | 2004 | 151 | 0.010 |
Why?
|
| Netrin-1 | 1 | 2003 | 4 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 388 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2004 | 211 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 26 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 27 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2003 | 35 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 194 | 0.010 |
Why?
|
| Receptors, Antigen | 1 | 2003 | 34 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 3653 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 2769 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 111 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 2003 | 72 | 0.010 |
Why?
|
| Growth Substances | 1 | 2003 | 114 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 747 | 0.010 |
Why?
|
| Integrases | 1 | 2004 | 162 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 774 | 0.010 |
Why?
|
| Cell Communication | 1 | 2003 | 165 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2004 | 338 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2004 | 349 | 0.010 |
Why?
|
| Zebrafish | 1 | 2004 | 372 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 1357 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 660 | 0.010 |
Why?
|
| Oxygen | 1 | 2004 | 544 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 467 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1524 | 0.010 |
Why?
|
| Aging | 1 | 2006 | 1157 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 1999 | 35 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 1999 | 65 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 1999 | 157 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1999 | 87 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1999 | 270 | 0.010 |
Why?
|
| Kidney | 1 | 2006 | 1323 | 0.010 |
Why?
|
| Biological Transport | 1 | 1999 | 348 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 654 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 1199 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1999 | 479 | 0.010 |
Why?
|